Cargando…
Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441960/ https://www.ncbi.nlm.nih.gov/pubmed/32835721 http://dx.doi.org/10.1016/j.ajog.2020.08.043 |
| _version_ | 1783573381167185920 |
|---|---|
| author | Carbillon, Lionel Benbara, Amelie Boujenah, Jeremy |
| author_facet | Carbillon, Lionel Benbara, Amelie Boujenah, Jeremy |
| author_sort | Carbillon, Lionel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7441960 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74419602020-08-24 Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment Carbillon, Lionel Benbara, Amelie Boujenah, Jeremy Am J Obstet Gynecol Letter to the Editor Elsevier Inc. 2021-01 2020-08-21 /pmc/articles/PMC7441960/ /pubmed/32835721 http://dx.doi.org/10.1016/j.ajog.2020.08.043 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Carbillon, Lionel Benbara, Amelie Boujenah, Jeremy Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title_full | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title_fullStr | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title_full_unstemmed | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title_short | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| title_sort | hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441960/ https://www.ncbi.nlm.nih.gov/pubmed/32835721 http://dx.doi.org/10.1016/j.ajog.2020.08.043 |
| work_keys_str_mv | AT carbillonlionel hydroxychloroquineatusualdosesasanoptionforcoronavirusdisease2019treatment AT benbaraamelie hydroxychloroquineatusualdosesasanoptionforcoronavirusdisease2019treatment AT boujenahjeremy hydroxychloroquineatusualdosesasanoptionforcoronavirusdisease2019treatment |